Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)

Summary

This study will test the safety and immunogenicity of an investigational Human Immunodeficiency Virus (HIV) vaccine. Immunogenicity will be measured by evaluating the immune response to several different dose levels.

Timeline

Start

2006-10

Primary completion

2008-05

Completion

2008-05

Drugs

Indications